Aurinia Pharmaceuticals Inc.·4

Aug 1, 4:13 PM ET

Habig Scott Michael 4

4 · Aurinia Pharmaceuticals Inc. · Filed Aug 1, 2022

Insider Transaction Report

Form 4
Period: 2022-08-01
Habig Scott Michael
Chief Commercial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-08-01+231,203231,203 total
    Exercise: $8.18Exp: 2032-08-01Common Stock (231,203 underlying)
  • Award

    Restricted Stock Units

    2022-08-01+137,531137,531 total
    Common Shares (137,531 underlying)
Footnotes (2)
  • [F1]One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.
  • [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning August 1, 2023.

Documents

1 file
  • 4
    wf-form4_165938478001230.xmlPrimary

    FORM 4